Dealings in securities by an associate of a director
Published: 2022-05-20 15:00:30 ET
[no company card]
Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
(“Ascendis Health” or “the Company”)
DEALINGS IN SECURITIES BY AN ASSOCIATE OF A DIRECTOR
In terms of paragraphs 3.63 to 3.74 of the Listings Requirements of the JSE Limited, the
following information, relating to dealings in securities by an associate of a director, is
disclosed:
Name of Director: Carl Neethling
Designation: Non-Executive Director
Name and relationship of associate: Dendrobium Capital Proprietary Limited
(“Dendrobium”). Carl Neethling is a director of
Dendrobium
Nature of transaction: On-market purchase
Class of securities: Ordinary shares
Extent of interest: Indirect beneficial
Clearance to deal: Clearance to deal was not obtained
Date of transaction: 12 May 2022
Highest price per share: R0.78
Lowest price per share: R0.65
Volume weighted average price per R0.69885
share:
Number of securities: 260 000
Total value of securities: R181 700
RESPONSIBILITY STATEMENT
The board of directors of Ascendis (the “Board”) accepts responsibility for the information
contained in this announcement as it pertains to Ascendis. To the best of the Board's
knowledge and belief, the information contained in this announcement as it pertains to
Ascendis is true and nothing has been omitted which is likely to affect the importance of such
information.
Bryanston
20 May 2022
Sponsor
Questco Corporate Advisory Proprietary Limited